Press "Enter" to skip to content

AstraZeneca’s Lynparza gets EU nod as first-line ovarian cancer maintenance treatment

BRCA genes are responsible for producing proteins which repair damaged DNA, and if the genes are mutated, they can cause cancer growth.

Original source:

Also Read:   Roche Pharma India expands partnership with Cipla for key oncology medicines